Home›Companies›Biotech & Pharma›Access Vascular

Access Vascular, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 30, 2023·Suggest an edit

About Access Vascular

Access Vascular is a private company based in Bedford, Massachusetts. It has reported $51,790,337 raised in six offerings on Form D since August 2017.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 13, 2023Oct 30, 2023$20,646,440of $31.5M target19$1.0MEquity, DebtRule 506(b)Form D ↗
Oct 6, 2022Oct 19, 2022$0of $10.0M target2$0Equity, DebtRule 506(b)Form D ↗
Feb 23, 2021Mar 9, 2021$19,895,191fully sold14$1.4MEquity, DebtRule 506(b)Form D ↗
Aug 23, 2019Sep 9, 2019$5,552,706of $7.2M target15$370KEquityRule 506(b)Form D ↗
May 4, 2018May 16, 2018$1,922,000of $4.0M target7$274KEquityRule 506(b)Form D ↗
Aug 7, 2017Aug 16, 2017$3,774,000fully sold25$150KEquityRule 506(b)Form D ↗
Total, six offerings$51,790,337

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Access Vascular's Form D filed Oct 30, 2023.

JP
AB
JB
James Biggins
President
LM
MJ
Michael Jaff
Director
MR
Marc Riviere
Director
BS
Brent Sabin
Director

Earlier filings also listed Paul Sabin (director, last listed Mar 2021), Brent Ratz (director, last listed Mar 2021), Alexandra MacLean (director, last listed Mar 2021) and Joseph Pellegrino (director, last listed May 2018).

Sources

  1. SECAccess Vascular, Inc. filing history